Pliant Therapeutics Inc
PLRX
Market Cap$941.69M
Close$
$0.84
94.5% downside
Current Fair Value
94.5% downsideOvervalued by 94.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $941.69 Million |
|---|---|
| Enterprise Value | $513.95 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-2.86 |
| Beta | 1.03 |
| Outstanding Shares | 60,325,832 |
| Avg 30 Day Volume | 442,730 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -5.52 |
|---|---|
| PEG | -22.01 |
| Price to Sales | - |
| Price to Book Ratio | 2.18 |
| Enterprise Value to Revenue | 2072.39 |
| Enterprise Value to EBIT | -2.64 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.11 |
| Debt to Equity | 0.12 |
Revenue Sources
No data
ESG Score
No data
About Pliant Therapeutics Inc
CEO: Bernard Coulie